ArticleNature communications2026
Structure of Blm10:13S proteasome intermediate reveals parallel assembly pathways for the proteasome core particle.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The proteasome core particle (CP) can be capped by Blm10/PA200, which promotes ATP-independent degradation of disordered proteins and contributes to attenuating antigenic diversity and impacts immunotherapy upon upregulation. The assembly process that leads to Blm10-CP proteasomes remains unresolved and Blm10 is present not only at mature proteasomes but also bound to assembly intermediates. We identified and solved structures of five CP intermediate complexes by cryo-electron microscopy, two of which include Blm10. We find that CP intermediates interactions with Blm10 and Pba1/Pba2 chaperone complex are mutually exclusive and both leads to mature CP production. We further find no synergy between Pba1/Pba2 and Blm10 for CP assembly. These data suggest a parallel assembly pathway exists for Blm10 proteasomes that does not require sequential activity with Pba1/Pba2. Whereas CP affinity for Pba1/Pba2 is reduced during maturation to promote its release, no such affinity switch occurs for Blm10, further suggesting a parallel Blm10-assembly pathway for production of mature Blm10-bound CPs. Altogether, our findings reveal a functionally distinct CP assembly pathway for the production of mature Blm10-CP proteasomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.